This article is sponsored by Otsuka America Pharmaceutical, Inc. In long-term care environments, it’s not uncommon for site staff including nurses, administrators, physical therapists, physicians and ...

Nuedexta (dextromethorphan/quinidine) is a brand-name drug prescribed for pseudobulbar affect (PBA) in adults. Nuedexta comes as an oral capsule that’s typically ...

PHILADELPHIA, Pennsylvania — A combination of dextromethorphan and quinidine (Nuedexta, Avanir Pharmaceuticals) significantly reduced symptoms of pseudobulbar affect (PBA) among patients with dementia ...

Perhaps this situation sounds familiar to you: you are having a calm discussion with a friend about a topic you don't find emotional whatsoever, and you notice that tears are welling up in your friend ...

Active ingredient: Dextromethorphan (DM) HBr 20 mg, quinidine sulfate 10 mg; capsules. Indication: To treat pseudobulbar affect (PBA). Pharmacology: DM is a sigma-1 receptor agonist and an ...

For five years, Rebecca (not her real name) often erupted in frequent crying spells. But thanks to her medical team’s vigilance and a good dose of serendipity, she’s now tear-free. Rebecca was 54 ...

Based on positive phase III study results, Metis Techbio is planning to file an NDA for its AI-derived orally disintegrating tablet drug candidate for pseudobulbar affect, MTS-004, in China next year.